Last update 08 May 2025

Dronedarone Hydrochloride/Ranolazine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Dronedarone/ranolazine, Ranolazine/dronedarone
Target
ADRA1 x SCNA x VDCCs x VGKCs x β1-adrenergic receptor
Action
antagonists, blockers
Mechanism
ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), SCNA blockers(Sodium voltage-gated channel alpha subunits blockers), VDCCs blockers(Voltage-gated calcium channel blockers)
+ [2]
Therapeutic Areas
Cardiovascular Diseases
Active Indication-
Inactive Indication
Atrial Fibrillation
Originator Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.
Active Organization-
Inactive Organization
Gilead Sciences, Inc.Gilead Sciences, Inc.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC31H45ClN2O5S
InChIKeyDWKVCQXJYURSIQ-UHFFFAOYSA-N
CAS Registry141625-93-6
View All Structures (2)

Related

100 Clinical Results associated with Dronedarone Hydrochloride/Ranolazine
Login to view more data
100 Translational Medicine associated with Dronedarone Hydrochloride/Ranolazine
Login to view more data
100 Patents (Medical) associated with Dronedarone Hydrochloride/Ranolazine
Login to view more data
100 Deals associated with Dronedarone Hydrochloride/Ranolazine
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Atrial FibrillationPhase 2
United States
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Atrial FibrillationPhase 2
Poland
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Atrial FibrillationPhase 2
Netherlands
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Atrial FibrillationPhase 2
Israel
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Atrial FibrillationPhase 2
Germany
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Atrial FibrillationPhase 2
United Kingdom
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Atrial FibrillationPhase 2
Italy
Gilead Sciences, Inc.Gilead Sciences, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free